Braslyn Ltd.'s Net Worth

$344 Million

Estimate Recalculated Nov 11, 2024 01:35PM EST

Who is Braslyn Ltd.

Braslyn Ltd. has an estimated net worth of $344 Million. This is based on reported shares across multiple companies, which include Mirati Therapeutics, Inc., Tango Therapeutics, Inc., INSEEGO CORP., Esperion Therapeutics, Inc., Solid Biosciences Inc., and Pandion Therapeutics Holdco LLC.

SEC CIK

Braslyn Ltd.'s CIK is 0001642355

Past Insider Trading and Trends

2017 was Braslyn Ltd.'s most active year for acquiring shares with 13 total transactions. Braslyn Ltd.'s most active month to acquire stocks was the month of December. 2020 was Braslyn Ltd.'s most active year for disposing of shares, totalling 41 transactions. Braslyn Ltd.'s most active month to dispose stocks was the month of September. 2017 saw Braslyn Ltd. paying a total of $32,169,808.18 for 5,754,047 shares, this is the most they've acquired in one year. In 2020 Braslyn Ltd. cashed out on 5,597,581 shares for a total of $228,777,517.36, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mirati Therapeutics, Inc.

Investor
Updated Jan 25, 2024
Form 4
-100.00%
-12.18M
Jan 25, 2024
Disposition
Jan 23
Form 4
-0.18%
-12.38K
$101.62
-$2.52M
Mar 10, 2021
6.71M
Sale
Mar 09 - Mar 10
Form 4
-5.61%
-400.00K
$106.97
-$85.57M
Oct 30, 2020
6.73M
Sale
Oct 28 - Oct 29
Form 4/A
-7.77%
-600.01K
$51.30
-$61.56M
Jun 16, 2020
7.13M
Sale
Jun 12
Form 4
-7.77%
-600.01K
$37.30
-$44.76M
Jun 16, 2020
7.13M
Sale
Jun 12
Form 4
-3.44%
-275.00K
$37.30
-$20.51M
Mar 05, 2019
7.73M
Sale
Mar 01
Form 4
63.65%
2.61M
$13.00
$33.99M
Nov 20, 2017
6.72M
Purchase
Nov 16
Form 4
$7.86
$2.11M
Oct 03, 2017
1.74M
Options
Oct 03
Form 4
1.70%
48.17K
$5.45
$262.33K
Jan 30, 2017
2.88M
Purchase
Jan 26
Form 4
2.81%
77.53K
$5.35
$414.57K
Jan 25, 2017
2.83M
Purchase
Jan 23 - Jan 25
Form 4
2.27%
61.16K
$5.46
$334.04K
Jan 20, 2017
2.76M
Purchase
Jan 18 - Jan 20
Form 4
4.66%
119.89K
$5.50
$658.86K
Jan 17, 2017
2.69M
Purchase
Jan 12 - Jan 17
Form 4
273.45%
5.45M
$5.60
$30.50M
Jan 10, 2017
7.44M
Purchase
Jan 06
Form 4
23.33%
376.90K
$9.96
$3.75M
Jun 08, 2016
1.99M
Purchase
Jun 06 - Jun 07
Form 4
4.25%
65.78K
$18.21
$1.20M
May 09, 2016
1.62M
Purchase
May 05 - May 06
Form 4
0.22%
3.40K
$19.09
$64.91K
Mar 31, 2016
1.55M
Purchase
Mar 29
Form 4
1.37%
20.85K
$19.36
$403.65K
Mar 28, 2016
1.55M
Purchase
Mar 24 - Mar 28
Form 4
0.08%
1.17K
$19.34
$22.55K
Mar 22, 2016
1.53M
Purchase
Mar 18
Form 4
32.67%
375.30K
Mar 17, 2016
1.52M
Acquisition
Mar 17
Form 4
119.84%
626.19K
Jan 15, 2016
1.15M
Acquisition
Jan 15
Form 4
-100.00%
-522.50K
Jan 05, 2016
2.98M
Disposition
Jan 04
Form 3
Jan 05, 2016
2.98M
Showing 22 results

Tango Therapeutics, Inc.

Investor
Updated Jan 04, 2022
Form 3
Jan 04, 2022
26.96K
Showing 1 results

Esperion Therapeutics, Inc.

Investor
Updated Oct 30, 2018
Form 3
Oct 30, 2018
2.60M
Showing 1 results

Solid Biosciences Inc.

Investor
Updated Mar 06, 2019
Form 3
Mar 06, 2019
3.96M
Showing 1 results

Pandion Therapeutics Holdco LLC

Investor
Updated Jul 21, 2020
Form 4
-70.34%
-5.05M
$18.00
Jul 21, 2020
2.13M
Buy-Options
Jul 21
Form 3
Jul 16, 2020
Showing 2 results

INSEEGO CORP.

Investor
Updated Dec 16, 2020
Form 4
-23.85%
-2.39M
$15.43
-$36.81M
Dec 16, 2020
7.61M
Sale
Dec 14 - Dec 16
Form 3
May 11, 2020
10.00M
Showing 2 results